Forbes December 3, 2025
In this week’s edition of InnovationRx, we look at the price cuts for blockbuster weight-loss drugs, the Forbes 30 Under 30 Healthcare list, the coming barriers to getting vaccines, and more.
More people may be able to afford GLP-1 weight-loss drugs following a flurry of recent announcements to cut prices and increase insurance coverage.
On Monday, Eli Lilly dropped prices for single-dose vials of its blockbuster weight-loss drug Zepbound for cash-paying customers on its direct-to-consumer website, LillyDirect. Its new prices range from $299 to $449 per month, depending on dosage, down from $349 to $499.
The announcement came after Lilly made a deal with the Trump Administration to cut prices of some of its most popular drugs for U.S. consumers,...
Today's Sponsors
Today's Sponsor